Clinical lipidology – an interactive educational meeting
Thursday 13 May 2010
Venue: Royal Society of Medicine, 1 Wimpole Street, LONDON, W1G 0AE
We are no longer accepting registrations for this meeting via the website. If you would like to attend this meeting, please contact Beilul Kahsai directly on 020 7290 3859.
Financial support for the costs for this meeting has been provided by Merck Sharp & Dohme Limited. Merck Sharp & Dohme Limited has not chosen the speakers or topics presented at this meeting.
Aim: The aim of the meeting is to provide the audience with evidence-based knowledge of the background and the day-to-day clinical management of patients with lipid disorders.
Objectives: At the end of this meeting the participants will be able to (1) describe and recognise common lipid disorders as seen in a typical specialist lipid clinic setting (2) clinically manage those patients according to evidence-based guidelines (3) value the evidence-based approach to clinical management.
Registration Details:
RSM Student: £15
Associate: £20
Trainee: £30
Allied Health Professional: £30
Consultant/GP: £80
Student: £20
RSM Trainee: £20
RSM Fellow: £50
Meeting ref: LIA03
CPD: 5 credits
9.00 am |
Registration, tea and coffee |
9.30 am |
Welcome and introduction to the audience response system |
| Dr Konstantinos Manolopoulos, Oxford Centre for Diabetes, Endocrinology and Metabolism Churchill Hospital Oxford | |
|
SESSION ONE |
|
9.45 am |
Terminology and basics of lipoprotein metabolism |
| Dr Fredrik Karpe, Oxford Centre for Diabetes, Endocrinology & Metabolism | |
10.15 am |
Assessment of hyperlipidaemic and cardiovascular risk |
| Professor Paul Durrington, Cardiovascular Research Group School of Biomedicine, University of Manchester | |
|
Common primary lipid disorders (case based) |
|
10.45 am |
Familial hypercholesterolaemia (FH) |
| Dr Mary Seed, Imperial College, London | |
|
Familial combined hyperlipidaemia (FCH) |
|
| Dr Paul Flynn, Addenbrooke's Hospital, Cambridge | |
11.45 am |
Tea and coffee break |
|
Continued: Common primary lipid disorders (case based) |
|
12.00 pm |
Type III hyperlipoproteinaemia |
| Professor Paul Durrington, Cardiovascular Research Group School of Biomedicine, University of Manchester | |
|
Extreme hypertriglyceridaemia |
|
|
Dr Fredrik Karpe, Oxford Centre for Diabetes, Endocrinology and Metabolism |
|
|
SESSION TWO |
|
1.00 pm |
Lunch |
2.00 pm |
Secondary hyperlipidaemias (case based) |
| Dr Hugh Simpson, Royal Berkshire Hospital, Reading and Professor Jane Armitage, University of Oxford | |
3.00 pm |
Tea and coffee break |
|
Interactive debate: Statin treatment in type 2 diabetes |
|
3.15 pm |
Motion: ''This house believes there is no significant benefit in using fibrates in the management of hyperlipidaemia in tytpe 2 diabetes'' |
|
Professor Paul Durrington, Cardiovascular Research Group School of Biomedicine, University of Manchester (Pro) Dr Hugh Simpson, Royal Berkshire Hospital, Reading (contra) Professor Jane Armitage, University of Oxford (moderator) |
|
3.50 pm |
Completion of evaluation forms |
4.00 pm |
Close of meeting |
